Redmile’s “Paper‑Trail” Shuffle: Insider Buying Fuels Optimism in Fate Therapeutics While Simplifying Ownership Structure
Redmile’s internal restructuring and insider equity purchases signal strategic confidence in Fate Therapeutics, hinting at growth while reducing regulatory complexity.
3 minutes to read